Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
基本信息
- 批准号:10630310
- 负责人:
- 金额:$ 84.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAllelesAngiopoietin-2Animal ModelAutomobile DrivingBar CodesBiologyBlood VesselsBlood capillariesBrainCell SeparationCell modelCell physiologyCellsChoroidCognitiveCollaborationsCoupledCutaneousDataDefectDermisDevelopmentEndothelial CellsEndotheliumEventExperimental ModelsEyeFaceFunctional disorderG alpha q ProteinG-substrateGNAQ geneGene Expression ProfileGenesGenomicsGenotypeGlaucomaGoalsGrowthHematopoieticHemorrhageHeterogeneityHeterotrimeric G Protein SubunitHistologicHumanImageImpairmentImplantIn Situ HybridizationIn VitroInfantInflammatoryKnock-inLeadLeptomeningesLesionMalignant NeoplasmsMassachusettsMediatorMedicalMedical centerModelingMolecularMorphogenesisMusMutationNF-kappa BNeurocutaneous SyndromesNeurologicNoduleNude MicePathogenesisPathologyPathway interactionsPatientsPharmaceutical PreparationsPharmacotherapyPhenotypePhospholipasePlayPort-Wine StainProtein Kinase CReportingResistanceRetinal DetachmentRoleSeizuresSignal TransductionSkinSmall Interfering RNASomatic MutationSortingSpecimenStainsSturge-Weber SyndromeSurfaceTNFSF5 geneTamoxifenTechnologyTestingTimeTissue EngineeringTranscriptUniversitiesWorkZebrafishcausal variantcell typecerebral capillarydrug candidatedrug testinghigh riskimprovedin vivoinsightknock-downmalformationmouse modelmutantnervous system disordernovelpreventresponseshear stresssingle-cell RNA sequencingskeletalsmall hairpin RNAsmall molecule inhibitorsoft tissuestroke-like episodesubcutaneoustissue repairtranscriptome sequencingvenule
项目摘要
Project Abstract
Our studies are focused on capillary malformation (CM) (previously referred to as “port-wine stain”), the most
common type of vascular malformation. CM, excessive, enlarged capillary-like vessels just below the surface
of the skin, are sporadic congenital lesions that darken, form nodules, and cause soft-tissue and skeletal
overgrowth beneath the stain. Sturge-Weber syndrome (SWS) is a neurocutaneous disorder associated with
CMs of the face, leptomeninges, and the choroid of the eye; patients suffer from neurological defects and
glaucoma. Importantly, drug treatment for CMs does not exist and there is no cure.
The 2013 discovery of a somatic activating mutation in GNAQ (p.R183Q) in non-syndromic cutaneous CMs
and SWS CMs set the stage for molecular studies of this understudied vascular malformation. GNAQ encodes
Gαq, the α-subunit of the heterotrimeric Gq protein that activates phospholipase Cβ. We showed that the
GNAQ R183Q allele is enriched in the endothelial cell (EC) sorted from cutaneous CM and SWS brain
specimens. We have worked on creating cellular and mouse models to elucidate how the GNAQ mutation
affects EC function, how these alterations lead to CM, and how we can prevent the formation or growth of CM.
We show that human ECs with the R183Q mutation do not respond properly to laminar shear stress, fail to
form an endothelial barrier, and form enlarged CM-like vessels when implanted into mice. We implicate protein
kinase C (PKC) and angiopoietin-2 (ANGPT2) as potential targets to reverse the GNAQ R183Q-driven CM.
We are making strong progress towards an inducible, endothelial-specific knock-in of Gnaq R183Q in mice in
which we have found CM-like lesions upon tamoxifen-induced expression of the knocked-in mutant allele.
In this proposal we will identify the breadth of cell types that carry the somatic GNAQ R183Q allele and how
the mutation alters the transcriptional profile versus non-mutant cells of the same phenotype (Aim 1). We will
develop novel animal models in mice and zebrafish to elucidate the cellular steps leading to CM and will use
them as platforms for testing candidate drugs (Aim 2). We will deeply interrogate the role of (ANGPT2) as a
downstream functional mediator of constitutively active, mutant Gαq (Aim 3). These studies will deepen our
understanding of how Gαq activity participates in capillary morphogenesis, result in the first animal models for
CM/SWS, and provide a platform to test drugs that can prevent or regress CM. Discoveries about the
pathophysiology of CM will also help us understand the mechanisms that underlie additional vascular lesions
and improve our ability to identify new pathways for preventing vascular overgrowth (e.g., cancer) and
promoting vascular growth during tissue repair or engineering.
项目摘要
我们的研究重点是毛细血管畸形 (CM)(以前称为“鲜红斑痣”),这是最常见的毛细血管畸形。
血管畸形的常见类型,即表面下方过多、增大的毛细血管样血管。
皮肤的散发性先天性病变,会变黑,形成结节,并导致软组织和骨骼损伤
污渍下过度生长综合征(SWS)是一种与相关的神经皮肤疾病。
面部、软脑膜和眼睛脉络膜的 CM 患者患有神经系统缺陷;
重要的是,目前尚无治疗青光眼的药物,也无法治愈。
2013 年在非综合征性皮肤 CM 中发现 GNAQ (p.R183Q) 体细胞激活突变
和 SWS CM 为这种尚未被研究的血管畸形编码的分子研究奠定了基础。
Gαq,异源三聚体 Gq 蛋白的 α 亚基,可激活磷脂酶 Cβ。
GNAQ R183Q 等位基因在从皮肤 CM 和 SWS 脑中分选的内皮细胞 (EC) 中富集
我们致力于创建细胞和小鼠模型来阐明 GNAQ 突变是如何发生的。
影响 EC 功能,这些改变如何导致 CM,以及我们如何预防 CM 的形成或生长。
我们表明,具有 R183Q 突变的人类 EC 不能正确响应层流剪切应力,无法
形成内皮屏障,并在植入小鼠体内时形成扩大的 CM 样血管。
激酶 C (PKC) 和血管生成素-2 (ANGPT2) 作为逆转 GNAQ R183Q 驱动的 CM 的潜在靶标。
我们正在小鼠体内诱导性内皮特异性敲入 Gnaq R183Q 方面取得了重大进展
我们发现他莫昔芬诱导敲入突变等位基因表达后出现CM样病变。
在本提案中,我们将确定携带体细胞 GNAQ R183Q 等位基因的细胞类型的广度以及如何
与相同表型的非突变细胞相比,突变改变了转录谱(目标 1)。
在小鼠和斑马鱼中开发新型动物模型,以阐明 CM 的细胞主导步骤,并将使用
它们作为测试候选药物的平台(目标2)我们将深入探讨(ANGPT2)作为测试药物的作用。
组成型活性突变 Gαq 的下游功能介导物(目标 3)。
了解 Gαq 活性如何参与毛细血管形态发生,产生了第一个动物模型
CM/SWS,并提供一个测试可以预防或逆转 CM 的药物的平台。
CM 的病理生理学还将帮助我们了解其他血管病变的机制
并提高我们发现预防血管过度生长(例如癌症)的新途径的能力
在组织修复或工程过程中促进血管生长。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A somatic missense mutation in GNAQ causes capillary malformation.
GNAQ 的体细胞错义突变导致毛细血管畸形。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:3.2
- 作者:Bichsel, Colette;Bischoff, Joyce
- 通讯作者:Bischoff, Joyce
MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge Weber syndrome.
Sturge Weber 综合征中 GNAQ p.R183Q 血管床中表达 MRC1 和 LYVE1 的巨噬细胞导致毛细血管畸形。
- DOI:
- 发表时间:2024-03-26
- 期刊:
- 影响因子:7.1
- 作者:Nasim, Sana;Bichsel, Colette;Dayneka, Stephen;Mannix, Robert;Holm, Annegret;Vivero, Mathew;Alexandrescu, Sanda;Pinto, Anna;Greene, Arin K;Ingber, Donald E;Bischoff, Joyce
- 通讯作者:Bischoff, Joyce
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joyce E. Bischoff其他文献
Joyce E. Bischoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joyce E. Bischoff', 18)}}的其他基金
Pediatric Surgeon-Scientist Training Program in Vascular Diseases
小儿外科医生-科学家血管疾病培训计划
- 批准号:
10331916 - 财政年份:2022
- 资助金额:
$ 84.07万 - 项目类别:
Pediatric Surgeon-Scientist Training Program in Vascular Diseases
小儿外科医生-科学家血管疾病培训计划
- 批准号:
10619547 - 财政年份:2022
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10414083 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations and disrupted endothelial biology
毛细血管畸形:来自体细胞 GNAQ 突变和内皮生物学破坏
- 批准号:
9244833 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10058384 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10206231 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Blood vessel assembly from multipotent hemangioma-derived stem cells
来自多能血管瘤干细胞的血管组装
- 批准号:
8248244 - 财政年份:2009
- 资助金额:
$ 84.07万 - 项目类别:
Blood vessel assembly from multipotent hemangioma-derived stem cells
来自多能血管瘤干细胞的血管组装
- 批准号:
10609870 - 财政年份:2009
- 资助金额:
$ 84.07万 - 项目类别:
Blood vessel assembly from multipotent hemangioma-derived stem cells
来自多能血管瘤干细胞的血管组装
- 批准号:
7677133 - 财政年份:2009
- 资助金额:
$ 84.07万 - 项目类别:
Blood vessel assembly from multipotent hemangioma-derived stem cells
来自多能血管瘤干细胞的血管组装
- 批准号:
10397566 - 财政年份:2009
- 资助金额:
$ 84.07万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
玉米穗行数QTL克隆及优异等位基因型鉴定
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Drug Development for Pediatric Capillary Malformation
治疗小儿毛细血管畸形的药物开发
- 批准号:
10536819 - 财政年份:2022
- 资助金额:
$ 84.07万 - 项目类别:
Drug Development for Pediatric Capillary Malformation
治疗小儿毛细血管畸形的药物开发
- 批准号:
10675489 - 财政年份:2022
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10414083 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10058384 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10206231 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别: